Health­care gi­ant Gri­fols ac­cused of ma­nip­u­lat­ing fi­nances by short sell­er Gotham City, stock plum­mets 

Plas­ma-de­rived med­i­cines man­u­fac­tur­ing com­pa­ny Gri­fols has been ac­cused of ma­nip­u­lat­ing its re­port­ed debt and EBIT­DA by UK-based hedge fund Gotham City Re­search, caus­ing its stock …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.